U.S. authorities subpoena GSK regarding diabetes drug Avandia

10/21/2010 | Wall Street Journal, The

GlaxoSmithKline has received a subpoena from the Justice Department and "civil investigative demands" from state authorities concerning the development and marketing of diabetes treatment Avandia. "These inquiries are at an early stage, and GSK is cooperating with these offices," the drugmaker said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Chief Financial Officer
B. E. Smith
Miramar, FL
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
Claims Director
PacificSource
Springfield, OR
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA